NVR CVI (Tekturna HCT 300 mg-12.5 mg)
Generic Name: aliskiren/hydrochlorothiazide
Pill with imprint NVR CVI is White, Elliptical / Oval and has been identified as Tekturna HCT 300 mg-12.5 mg. It is supplied by Novartis Pharmaceuticals.
Tekturna HCT is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Tekturna HCT 300 mg-12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR CVI
Tekturna HCT
- Generic Name
- aliskiren/hydrochlorothiazide
- Imprint
- NVR CVI
- Strength
- 300 mg-12.5 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antihypertensive combinations
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- National Drug Code (NDC)
- 00078-0523
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
hypromelloses,
ferric oxide red,
lactose,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
povidone,
magnesium silicate,
titanium dioxide,
wheat starch
Note: Inactive ingredients may vary.
More about Tekturna HCT (aliskiren / hydrochlorothiazide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: miscellaneous antihypertensive combinations
- FDA Alerts (1)
- FDA Approval History
Consumer resources
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.